GLP-1 agonists themselves slow gastric emptying as part of their mechanism, potentially amplifying nausea or fullness during high-progesterone phases
States Offering Partial GLP-1 Coverage for Obesity: Another 22 states, including Texas, Arizona, and Washington, offer partial coverage for obesity-specific GLP-1s
Retatrutide reduces appetite but does not eliminate the impact of calorie-dense food choices, alcohol consumption, poor sleep, or chronic stress, all of which can counteract the drug's effects
Before making any changes to your GLP-1 medication management, consider these factors: Current treatment response: If your injectable medication is working well, switching may not offer additional benefits Lifestyle compatibility: The empty stomach requirement and 30-minute waiting period requires consistent daily scheduling Cost considerations: Insurance coverage for the pill may differ from injectable coverage initially Other medications: The timing restrictions may complicate existing medication schedules Optimizing Your Results: Beyond the Medication Whether you choose oral or injectable GLP-1 treatment, medication alone isnt the complete picture
What does the Longevity Program include